CBS News Staffers on the Verge of Revolt If This Person Is Hired
As Puerto Ricans Call for Independence Their Dreams Are Blocked By Their Chief...
President Trump Closes the Overton Window
The Fake Stream Media’s Pervasive Assault on Black America
Mamdani: More Continuation Than Aberration for New York
President Trump Is Bringing the Spirit of Sports Back to America
Money, Power and Transgender Ideology
Cleaning Up the Swamp Is a Full-Time Job for Trump
Iran's Mullahs Staring Into the Abyss
The Party of Losers Is Not Funny
The Enduring Lie of Socialism
DOJ: Minnesota Duo Orchestrated Kidnappings, Bombings in Africa
Michigan Woman Indicted for Smuggling Illegal Aliens, Children, Across the Northern Border
Tennessee Joins 25-State Coalition Defending Second Amendment Rights for Travelers
DOD Calls Out 'Highly Provocative' Move by Venezuela
Tipsheet

New CDC Study Shows How Quickly Booster Effectiveness Wanes

AP Photo/Alastair Grant, File

A study released Friday by the U.S. Centers for Disease Control and Prevention shows that the booster shots of the Pfizer-BioNTech and Moderna vaccine lose substantial effectiveness after about four months but still provide protection against hospitalization.

Advertisement

According to the study, researchers found that boosters were effective against cases of moderate and severe COVID-19 for two months after the dose. The effectiveness dropped by the fourth month after the booster dose. But, the booster shots still provided protection in keeping people out of hospitals during the Delta and Omicron variant surge.

The booster was 91 percent effective in preventing a vaccinated person from COVID-19 hospitalization the first two months after receiving their booster shot. Four months after getting boosted, protection dropped to 78 percent. 

The study found that trips to urgent care and emergency departments fell from 87 percent in the first two months after getting boosted to 66 percent after four months. After more than five months after receiving the booster, protection dropped to 31 percent.

The study analyzed hospitalizations and emergency room and urgent care visits from 10 states from Aug. to Jan. 22, 2022. This span covers when Delta and Omicron were dominant. In the study, over 50 percent of people hospitalized were over 65 years old. 10 percent were boosted.

Advertisement

The Washington Post noted that “the report did not evaluate the variations in waning immunity by age, underlying health conditions, or a person’s immunocompromised status.”

The study suggested that more boosters may be needed in the future.

"These findings underscore the importance of receiving a third dose of mRNA COVID-19 vaccine to prevent both COVID-19–associated [emergency department and urgent care] encounters and COVID-19 hospitalizations among adults. The finding that protection conferred by mRNA vaccines waned in the months after receipt of a third vaccine dose reinforces the importance of further consideration of additional doses to sustain or improve protection against COVID-19–associated [emergency department and urgent care] encounters and COVID-19 hospitalizations," the study stated. 

"All eligible persons should remain up to date with recommended COVID-19 vaccinations to best protect against COVID-19–associated hospitalizations and ED/UC visits,” it added.

On Wednesday, Dr. Anthony Fauci, President Biden’s chief medical adviser, said during a White House COVID-19 briefing that decisions surrounding boosters would depend on “efficacy in preventing, for example, hospital visits, as well as hospitalizations.”

Advertisement

In September, two top U.S. Food and Drug Administration vaccine regulators, Dr. Marion Gruber and Dr. Philip Krause, departed their roles due to the Biden administration’s push for booster shots for the general public. In an article titled “Considerations in boosting COVID-19 vaccine immune responses,” Krause and Gruber, as well as other doctors, argued that “current evidence does not, therefore, appear to show a need for boosting in the general population, in which efficacy against severe disease remains high,” and that “the currently available evidence does not show the need for widespread use of booster vaccination in populations that have received an effective primary vaccination regimen.”

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement